Platelet-Inhibitor Drug Trial in Coronary Angioplasty

• Status: Completed
• Trial end date: 1988-09-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine the effectiveness of dipyridamole and aspirin in prevention of restenosis of the dilated lesion in patients who had undergone percutaneous transluminal coronary angioplasty (PTCA). Secondary aims were to determine the effectiveness of platelet inhibitor therapy in reducing the incidence of coronary events and the severity and incidence of angina.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Aspirin; Dipyridamole

Criteria

Patients to age 80 with angina pectoris.